(HealthDay News) — Despite smaller, prior studies suggesting that pioglitazone might raise users’ risk of bladder cancer, a large new study finds no statistically significant association. The research ...

Nevada case involves allegations that women developed cancer as a result of Actos medication. National network of attorneys is offering no-cost consultations to consumers seeking compensation over ...

Although some previous studies have suggested an increased risk of bladder cancer with use of the diabetes drug pioglitazone, analyses that included nearly 200,000 patients found no statistically ...

The FDA has added a warning to the label for Actos (pioglitazone) stating that the use of the medication for more than one year may be associated with an increased risk of bladder cancer. The ...

LAFAYETTE, La., April 8, 2014 /PRNewswire/ -- A Louisiana jury has awarded $9 billion to a New York man and his wife following a trial over the man's claims that his bladder cancer was caused by the ...

OBJECTIVE To determine whether pioglitazone compared with other antidiabetic drugs is associated with an increased risk of bladder cancer in people with type 2 diabetes. DESIGN Population based cohort ...

W. Mark Lanier said close to 3,000 plaintiffs are in the MDL. He said hundreds of them are from Texas. When Houston's W. Mark Lanier won a verdict in a pharmaceutical case that includes $9 billion in ...

Cancer Monthly is reporting on new research published by PLoS One suggesting that the diabetes drug Actos, which is already associated with an increased risk of bladder cancer, may also increase the ...

Actos pioglitazone is a once-daily mere medication for people with adverse 2 diabetes. As specified above, Actos has been linked to a significantly cost of actos excretion of bladder cancer in some ...